Clinical Research, Pharma & Healthcare FinancingBayer to Present Phase III OCEANIC-STROKE ResultsBusiness WireJanuary 27, 2026January 28, 2026 by Business WireJanuary 27, 2026January 28, 2026012 Bayer today announced that the main results from its global, landmark Phase III study OCEANIC-STROKE of asundexian in secondary stroke prevention, will be presented during...
